Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/16/2013 | CN102276727B IL-17RC-hFc fusion protein and application thereof |
10/16/2013 | CN102209550B Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng |
10/16/2013 | CN102051362B Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof |
10/16/2013 | CN101936984B Method and special chemical luminous immunoassay kit for detecting clenbuterol |
10/16/2013 | CN101935342B Moth orchid development B gene-PhAP3 coded sequence and application thereof |
10/16/2013 | CN101806804B Reagent for detecting acute myocardial infarction by immunological method and test strip |
10/16/2013 | CN101535344B Novel antiproliferation antibodies |
10/16/2013 | CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146 |
10/15/2013 | US8558094 Inbred sunflower (Helianthus annuus) line, designated OID687R |
10/15/2013 | US8558093 Inbred sunflower (Helianthus annuus) line, designated CN5190R |
10/15/2013 | US8558087 Hybrid corn variety 980004 |
10/15/2013 | US8558084 Plants and seeds of corn variety CV198691 |
10/15/2013 | US8558072 Soybean variety XBP32005 |
10/15/2013 | US8558069 Inbred Cucurbita pepo pumpkin HSPMR7B1 having a mutant allele for powdery mildew resistance |
10/15/2013 | US8558068 Sclerotinia-resistant Brassica |
10/15/2013 | US8558067 Sclerotinia-resistant brassica |
10/15/2013 | US8558066 Sclerotinia-resistant Brassica |
10/15/2013 | US8557967 Anti-interferon-α antibodies |
10/15/2013 | US8557785 In vivo production of small interfering RNAS that mediate gene silencing |
10/15/2013 | US8557584 Preparing a homogenous population of stem cells committed to differentiated to a specific cell type |
10/15/2013 | US8557583 Cell culture support and manufacture thereof |
10/15/2013 | US8557582 System, apparatus and method for applying mechanical force to a material |
10/15/2013 | US8557581 Soft tissue processing |
10/15/2013 | US8557580 Methods and compositions for the differentiation of stem cells |
10/15/2013 | US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death |
10/15/2013 | US8557577 Solid phase cell isolation and/or enrichment method |
10/15/2013 | US8557576 Mineralized three-dimensional bone constructs |
10/15/2013 | US8557575 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
10/15/2013 | US8557574 Fungal growth inhibitor |
10/15/2013 | US8557547 Phosphotriesterase from agrobacterium radiobacter P230 |
10/15/2013 | US8557543 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
10/15/2013 | US8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 |
10/15/2013 | US8557513 Methods for treating and/or limiting development of diabetes |
10/15/2013 | US8557512 Method of screening activators and/or inhibitors of insulin receptor substrate 2 |
10/15/2013 | US8557295 Use of cellular extracts for skin rejuvenation |
10/15/2013 | US8557246 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
10/15/2013 | US8557235 Bone substitute compositions, methods of preparation and clinical applications |
10/15/2013 | CA2715103C Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
10/15/2013 | CA2673085C Transferrin fusion protein libraries |
10/15/2013 | CA2555699C Monoclonal antibody based biomarker discovery and development platform |
10/15/2013 | CA2533926C Methods and compositions for producing antigenic responses |
10/15/2013 | CA2521946C Method of identifying transmembrane protein-interacting compounds |
10/15/2013 | CA2494844C Methods and compositions concerning poxviruses and cancer |
10/15/2013 | CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
10/15/2013 | CA2410762C Feline hepatocyte growth factor |
10/15/2013 | CA2402214C T1r taste receptors and genes encoding same |
10/15/2013 | CA2373721C Compounds that bind her2 |
10/15/2013 | CA2333146C Commercial production of proteases in plants |
10/15/2013 | CA2296434C Mutations in the myostatin gene cause double-muscling in mammals |
10/15/2013 | CA2236749C Neuronal stimulation using electrically conducting polymers |
10/10/2013 | WO2013152274A1 Epitope- scaffold immunogens against respiratory syncytial virusm (rsv) |
10/10/2013 | WO2013151735A1 Method to mitigate long-qt arrhythmias |
10/10/2013 | WO2013151725A1 Regenerative sera cells and mesenchymal stem cells |
10/10/2013 | WO2013151186A1 Method for inducing erythropoietin-producing cell |
10/10/2013 | WO2013151058A1 DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA |
10/10/2013 | WO2013150400A1 Plants having one or more enhanced yield-related traits and method for making same |
10/10/2013 | WO2013150303A1 Stem cell microparticles |
10/10/2013 | WO2013150138A1 Secretory immunoglobulin complex |
10/10/2013 | WO2013149957A1 Improved culture media for embryonic cells |
10/10/2013 | US20130269065 Blackleg resistance gene |
10/10/2013 | US20130269047 Tomato hybrid px 02461513 and parents thereof |
10/10/2013 | US20130268060 Method for differentiating embryonic stem cells into cells expressing aqp-1 |
10/10/2013 | US20130267684 Method for preparing aqueous solution containing culture medium and chelating agent |
10/10/2013 | US20130267676 Artificial antibody polypeptides |
10/10/2013 | US20130267468 Factor viii glycoforms |
10/10/2013 | US20130267455 Crosslinked peptide hydrogels |
10/10/2013 | US20130267030 Efficient method for establishing induced pluripotent stem cells |
10/10/2013 | US20130267027 Dry granulated cell culture media |
10/10/2013 | US20130267026 Methods of building a body portion |
10/10/2013 | US20130267024 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
10/10/2013 | US20130267023 Multiple Inducible Gene Regulation System |
10/10/2013 | US20130267008 Freezing medium composition for cryopreserving amniotic fluid-derived stem cells and a method for cryopreserving the same |
10/10/2013 | US20130266985 Process for Cell Culturing by Continuous Perfusion |
10/10/2013 | US20130266954 Method for forming a cell aggregate |
10/10/2013 | US20130266939 Systems and methods for studying inflammation-drug interactions |
10/10/2013 | US20130266628 Graphene-based antimicrobial composites |
10/10/2013 | US20130266573 Specific binding proteins and uses thereof |
10/10/2013 | US20130266553 Albumin Fusion Proteins |
10/10/2013 | US20130266544 Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors |
10/10/2013 | US20130266543 Multipotent Adult Stem Cell Population |
10/10/2013 | US20130266541 Human induced pluripotent stem cells |
10/10/2013 | DE102010022675B4 Verfahren zur Herstellung einer Hydrogel-Mikrostruktur A process for the preparation of a hydrogel microstructure |
10/10/2013 | CA2808845A1 Promoters and methods for transforming tubers and transformed tubers |
10/09/2013 | EP2647707A1 Cytotoxicity-inducing therapeutic agent |
10/09/2013 | EP2647700A1 Method for increasing efficiency of generating inducted pluripotent stem cell |
10/09/2013 | EP2647699A1 Efficient method for establishing induced pluripotent stem cells |
10/09/2013 | EP2647698A1 Method for production of eosinophil from pluripotent stem cell |
10/09/2013 | EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound |
10/09/2013 | EP2647384A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Va-Ja , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS |
10/09/2013 | EP2646557A1 Method for cellular rna expression |
10/09/2013 | EP2646546A1 Tomm34 peptides and vaccines including the same |
10/09/2013 | EP2646545A1 TEMPERATURE-STABLE ß-PYRANOSIDASE |
10/09/2013 | EP2646543A1 Methods of generating corneal cells and cell populations comprising same |
10/09/2013 | EP2646045A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease |
10/09/2013 | EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
10/09/2013 | CN103348012A Humanized transgenic animal |
10/09/2013 | CN103348003A Fusion enzymes having N-acetylglucosaminyl transferase activity |
10/09/2013 | CN103348002A Method of generating induced pluripotent stem cells and differentiated cells |
10/09/2013 | CN103348001A Highly functional liver cells derived from pluripotent stem cells, method for producing same, and method for testing metabolism/toxicity of drug |
10/09/2013 | CN103348000A Compositions and methods for stabilizing susceptible compounds |